Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
Rag1-/- mice transferred with splenocytes of M3 muscarinic acetylcoline receptor (M3R)-/- mice immunized with M3R peptides mixture (N-terminal regions; N1, N2, N3, and three extracellular loops; 1st, 2nd, 3rd) developed sialadenitis like Sjogren’s syndrome (SS) (M3R induced sialadenitis; MIS). we confirmed that in MIS, M3R reactive CD4+ T cells were indispensable and the T cell epitopes were both N1 and 1st regions. Besides, altered peptide ligands (APLs) , substituted in amino acid residues at TCR contact sites, of N1 peptide can regulate the T cell activation by inducing anergy, leading to the suppression of sialadenitis in vivo. This research was reported by the journal of 'Arthritis and Rheumatology'.
|